The reduction of R1, a novel repressor protein for monoamine oxidase a, in major depressive disorder

Neuropsychopharmacology

Volumn 36, Issue 10, 2011, Pages 2139-2148

  Johnson, Shakevia ^a   Stockmeier, Craig A ^a,b   Meyer, Jeffrey H ^c   Austin, Mark C ^a   Albert, Paul R ^d   Wang, Junming ^a   May, Warren L ^e   Rajkowska, Grazyna ^a   Overholser, James C ^b   Jurjus, George ^b   Dieter, Lesa ^b   Johnson, Chandra ^a   Sittman, Donald B ^e   Ou, Xiao Ming ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c UNIVERSITY OF TORONTO   (Canada)

^d OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^e UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

major depressive disorder; monoamine oxidase; prefrontal cortex; selective serotonin reuptake inhibitor; transcriptional repressor protein; treatment

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; PROTEIN R1; REPRESSOR PROTEIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; AUTOPSY; CATALYSIS; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; MAJOR DEPRESSION; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION;

APOPTOSIS; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; MALE; MIDDLE AGED; MONOAMINE OXIDASE; REPRESSOR PROTEINS; RETROSPECTIVE STUDIES;

EID: 80051783568     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2011.105     Document Type: Article

References (57)

1. Andreazza AC, Shao L, Wang JF, Young LT (2010). Mitochondrial complex I activity and oxidative damage to mitochondrial proteins in the prefrontal cortex of patients with bipolar disorder. Arch Gen Psychiatry 67: 360-368.
2. Bartholomeeusen K, De Rijck J, Busschots K, Desender L, Gijsbers R, Emiliani S et al (2007). Differential interaction of HIV-1 integrase and JPO2 with the C terminus of LEDGF/p75. J Mol Biol 372: 407-421. (Pubitemid 47267963)
3. Beck GJ, Doyle CA, Schachter EN (1981). Smoking and lung function. Am Rev Respir Dis 123: 149-155. (Pubitemid 11146386)
4. Cases O, Seif I, Grimsby J, Gaspar P, Chen K, Pournin S et al (1995). Aggressive behavior and altered amounts of brain serotonin and norepinephrine in mice lacking MAOA. Science (New York, NY) 268: 1763-1766.
5. Chen K, Ou XM, Chen G, Choi SH, Shih JC (2005). R1, a novel repressor of the human monoamine oxidase A. J Biol Chem 280: 11552-11559. (Pubitemid 40418467)
6. Chen K, Ou XM, Wu JB, Shih JC (2011). Transcription factor E2F-associated phosphoprotein (EAPP), RAM2/CDCA7L/JPO2 (R1), and simian virus 40 promoter factor 1 (Sp1) cooperatively regulate glucocorticoid activation of monoamine oxidase B. Mol Pharmacol 79: 308-317.
7. Chouinard G, Young SN, Annable L (1985). A controlled clinical trial of L-tryptophan in acute mania. Biol Psychiatry 20: 546-557. (Pubitemid 16033752)
8. De Zutter GS, Davis RJ (2001). Pro-apoptotic gene expression mediated by the p38 mitogen-activated protein kinase signal transduction pathway. Proc Natl Acad Sci USA 98: 6168-6173. (Pubitemid 32488211)
9. Deep-Soboslay A, Akil M, Martin CE, Bigelow LB, Herman MM, Hyde TM et al (2005). Reliability of psychiatric diagnosis in postmortem research. Biol Psychiatry 57: 96-101. (Pubitemid 39647597)
10. Dejong TM, Overholser JC (2009). Assessment of depression and suicidal actions: agreement between suicide attempters and informant reports. Suicide Life Threat Behav 39: 38-46.
11. Du L, Bakish D, Ravindran A, Hrdina PD (2004). MAO-A gene polymorphisms are associated with major depression and sleep disturbance in males. Neuroreport 15: 2097-2101. (Pubitemid 39281754)
12. Du L, Faludi G, Palkovits M, Sotonyi P, Bakish D, Hrdina PD (2002). High activity-related allele of MAO-A gene associated with depressed suicide in males. Neuroreport 13: 1195-1198. (Pubitemid 34722052)
13. Duman RS, Monteggia LM (2006). A neurotrophic model for stress-related mood disorders. Biol Psychiatry 59: 1116-1127.
14. Dwivedi Y, Mondal AC, Rizavi HS, Faludi G, Palkovits M, Sarosi A et al (2006). Differential and brain region-specific regulation of Rap-1 and Epac in depressed suicide victims. Arch Gen Psychiatry 63: 639-648. (Pubitemid 43848295)
15. Dwivedi Y, Rizavi HS, Conley RR, Roberts RC, Tamminga CA, Pandey GN (2003). Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects. Arch Gen Psychiatry 60: 804-815. (Pubitemid 36960912)
16. Dwivedi Y, Rizavi HS, Zhang H, Mondal AC, Roberts RC, Conley RR et al (2009). Neurotrophin receptor activation and expression in human postmortem brain: effect of suicide. Biol Psychiatry 65: 319-328.
17. Egede LE (2004). Diabetes, major depression, and functional disability among U.S. adults. Diabetes Care 27: 421-428. (Pubitemid 38174067)
18. Fan M, Liu B, Jiang T, Jiang X, Zhao H, Zhang J (2010). Meta-analysis of the association between the monoamine oxidase-A gene and mood disorders. Psychiatr Genet 20: 1-7.
19. First MBSR, Gibbon M, Williams JBW (1996). Structured Clinical Interview for DSM-IV Axis I DisordersFPatient Edition, Version 2.0 ed. Biometrics Research Department, New York State Psychiatric Institute: New York.
20. Fowler JS, Volkow ND, Wang GJ, Pappas N, Logan J, Shea C et al (1996). Brain monoamine oxidase A inhibition in cigarette smokers. Proc Natl Acad Sci USA 93: 14065-14069. (Pubitemid 26424246)
21. Gawryluk JW, Wang JF, Andreazza AC, Shao L, Young LT (2010). Decreased levels of glutathione, the major brain antioxidant, in post-mortem prefrontal cortex from patients with psychiatric disorders. Int J Neuropsychopharmacol 14: 1-8.
22. Goridis C, Neff NH (1971). Monoamine oxidase in sympathetic nerves: a transmitter specific enzyme type. Br J Pharmacol 43: 814-818.
23. Greer S, Honeywell R, Geletu M, Arulanandam R, Raptis L (2010). Housekeeping genes; expression levels may change with density of cultured cells. J Immunol Meth 355: 76-79.
24. Huang A, Ho CS, Ponzielli R, Barsyte-Lovejoy D, Bouffet E, Picard D et al (2005). Identification of a novel c-Myc protein interactor, JPO2, with transforming activity in medulloblastoma cells. Cancer Res 65: 5607-5619. (Pubitemid 40911161)
25. Kang HJ, Adams DH, Simen A, Simen BB, Rajkowska G, Stockmeier CA et al (2007). Gene expression profiling in postmortem prefrontal cortex of major depressive disorder. J Neurosci 27: 13329-13340. (Pubitemid 350220503)
26. Keller MB, Boland RJ (1998). Implications of failing to achieve successful long-term maintenance treatment of recurrent unipolar major depression. Biol Psychiatry 44: 348-360. (Pubitemid 28432646)
27. Kelly TM, Mann JJ (1996). Validity of DSM-III-R diagnosis by psychological autopsy: a comparison with clinician ante-mortem diagnosis. Acta Psychiatrica Scandinavica 94: 337-343. (Pubitemid 26396309)
28. Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR et al (2003). The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 289: 3095-3105. (Pubitemid 37432885)
29. Klimek V, Zhu MY, Dilley G, Konick L, Overholser JC, Meltzer HY et al (2001). Effects of long-term cigarette smoking on the human locus coeruleus. Arch Gen Psychiatry 58: 821-827. (Pubitemid 32979299)
30. Kunduzova OR, Bianchi P, Parini A, Cambon C (2002). Hydrogen peroxide production by monoamine oxidase during ischemia/reperfusion. Eur J Pharmacol 448: 225-230. (Pubitemid 34874591)
31. Leroy C, Bragulat V, Berlin I, Gregoire MC, Bottlaender M, Roumenov D et al (2009). Cerebral monoamine oxidase A inhibition in tobacco smokers confirmed with PET and [11C]befloxatone. J Clin Psychopharmacol 29: 86-88.
32. Maertens GN, Cherepanov P, Engelman A (2006). Transcriptional co-activator p75 binds and tethers the Myc-interacting protein JPO2 to chromatin. J Cell Sci 119: 2563-2571. (Pubitemid 44070437)
33. Meyer JH, Ginovart N, Boovariwala A, Sagrati S, Hussey D, Garcia A et al (2006). Elevated monoamine oxidase a levels in the brain: an explanation for the monoamine imbalance of major depression. Arch Gen Psychiatry 63: 1209-1216. (Pubitemid 44708079)
34. Meyer JH, Wilson AA, Sagrati S, Miler L, Rusjan P, Bloomfield PM et al (2009). Brain monoamine oxidase A binding in major depressive disorder: relationship to selective serotonin reuptake inhibitor treatment, recovery, and recurrence. Arch Gen Psychiatry 66: 1304-1312.
35. Morilak DA, Frazer A (2004). Antidepressants and brain mono-aminergic systems: a dimensional approach to understanding their behavioural effects in depression and anxiety disorders. Int J Neuropsychopharmacol 7: 193-218. (Pubitemid 38823288)
36. Ou XM, Chen K, Shih JC (2006a). Glucocorticoid and androgen activation of monoamine oxidase A is regulated differently by R1 and Sp1. J Biol Chem 281: 21512-21525. (Pubitemid 44115488)
37. Ou XM, Chen K, Shih JC (2006b). Monoamine oxidase A and repressor R1 are involved in apoptotic signaling pathway. Proc Natl Acad Sci USA 103: 10923-10928. (Pubitemid 44148396)
38. Ou XM, Lu D, Johnson C, Chen K, Youdim MB, Rajkowska G et al (2009a). Glyceraldehyde-3-phosphate dehydrogenase-monoa-mine oxidase B-mediated cell death-induced by ethanol is prevented by rasagiline and 1-R-aminoindan. Neurotox Res 16: 148-159.
39. Ou XM, Stockmeier CA, Meltzer HY, Overholser JC, Jurjus GJ, Dieter L et al (2009b). A novel role for glyceraldehyde-3-phosphate dehydrogenase and monoamine oxidase B cascade in ethanol-induced cellular damage. Biol Psychiatry 67: 855-863.
40. Ou XM, Storring JM, Kushwaha N, Albert PR (2001). Hetero-dimerization of mineralocorticoid and glucocorticoid receptors at a novel negative response element of the 5-HT1A receptor gene. J Biol Chem 276: 14299-14307.
41. Rajkowska G, Miguel-Hidalgo JJ, Dubey P, Stockmeier CA, Krishnan KR (2005). Prominent reduction in pyramidal neurons density in the orbitofrontal cortex of elderly depressed patients. Biol Psychiatry 58: 297-306. (Pubitemid 41133623)
42. Reilly JG, McTavish SF, Young AH (1997). Rapid depletion of plasma tryptophan: a review of studies and experimental methodology. J Psychopharmacol 11: 381-392. (Pubitemid 27526048)
43. Sacher J, Wilson AA, Houle S, Rusjan P, Hassan S, Bloomfield PM et al (2010). Elevated brain monoamine oxidase A binding in the early postpartum period. Arch Gen Psychiatry 67: 468-474.
44. Sanacora G (2008). New understanding of mechanisms of action of bipolar medications. J Clin Psychiatry 69(Suppl 5): 22-27.
45. Schmidt HD, Duman RS (2007). The role of neurotrophic factors in adult hippocampal neurogenesis, antidepressant treatments and animal models of depressive-like behavior. Behav Pharmacol 18: 391-418. (Pubitemid 47356367)
46. Sherif F, Marcusson J, Oreland L (1991). Brain gamma-aminobu-tyrate transaminase and monoamine oxidase activities in suicide victims. Eur Arch Psychiatry Clin Neurosci 241: 139-144.
47. Shih JC (1991). Molecular basis of human MAO A and B. Neuropsychopharmacology 4: 1-7.
48. Shih JC, Chen K (1999). MAO-A and-B gene knock-out mice exhibit distinctly different behavior. Neurobiology (Bp) 7: 235-246. (Pubitemid 30353425)
49. Shih JC, Grimsby J, Chen K, Zhu QS (1993). Structure and promoter organization of the human monoamine oxidase A and B genes. J Psychiatry Neurosci 18: 25-32.
50. Stockmeier CA, Howley E, Shi X, Sobanska A, Clarke G, Friedman L et al (2009). Antagonist but not agonist labeling of serotonin-1A receptors is decreased in major depressive disorder. J Psychiatr Res 43: 887-894.
51. Tatsumi M, Groshan K, Blakely RD, Richelson E (1997). Pharmacological profile of antidepressants and related compounds at human monoamine transporters. Eur J Pharmacol 340: 249-258. (Pubitemid 28022649)
52. Thalmeier A, Dickmann M, Giegling I, Schneider B, A MH, Maurer K et al (2008). Gene expression profiling of post-mortem orbitofrontal cortex in violent suicide victims. Int J Neuropsy-chopharmacol 11: 217-228. (Pubitemid 351231822)
53. Youdim MB, Bakhle YS (2006). Monoamine oxidase: isoforms and inhibitors in Parkinson's disease and depressive illness. Br J Pharmacol 147(Suppl 1): S287-S296. (Pubitemid 43077287)
54. Youdim MB, Edmondson D, Tipton KF (2006). The therapeutic potential of monoamine oxidase inhibitors. Nat Rev 7: 295-309.
55. Youdim MB, Fridkin M, Zheng H (2004). Novel bifunctional drugs targeting monoamine oxidase inhibition and iron chelation as an approach to neuroprotection in Parkinson's disease and other neurodegenerative diseases. J Neural Transm 111: 1455-1471. (Pubitemid 39468399)
56. Young SN, Smith SE, Pihl RO, Ervin FR (1985). Tryptophan depletion causes a rapid lowering of mood in normal males. Psychopharmacology (Berl) 87: 173-177. (Pubitemid 16253342)
57. Zhu QS, Chen K, Shih JC (1994). Bidirectional promoter of human monoamine oxidase A (MAO A) controlled by transcription factor Sp1. J Neurosci 14: 7393-7403.